Katie Kalvaitis
@katiekalvaitis.bsky.social
59 followers 280 following 17 posts
Medical journalist @gohealio.bsky.social
Posts Media Videos Starter Packs
Reposted by Katie Kalvaitis
katiekalvaitis.bsky.social
Catch up on news from the European Society of Cardiology Congress:

🫀 Digitoxin for HFrEF
🫀 Beta-blockers after heart attack
🫀 New treatments for obstructive + nonobstructive HCM
🫀 Baxdrostat for resistant hypertension
🫀 + more

www.healio.com/news/cardiol...

#ESCCongress @gohealio.bsky.social
European Society of Cardiology
The latest news from the ESC Congress, with physician perspective, researcher interviews and clinician insight.
www.healio.com
katiekalvaitis.bsky.social
☕️ Healio is live in Boston for the
@aspcardio.bsky.social Congress on CVD Prevention

Stay tuned for the latest updates on prevention of heart disease and more!

#ASPC2025 #CardioSky @gohealio.bsky.social
katiekalvaitis.bsky.social
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal hormone therapy and how to better educate patients and health care professionals

Read coverage from @gohealio.bsky.social, with reaction from experts in the field

#Endosky #Medsky

www.healio.com/news/endocri...
FDA panel calls for label changes, more education on menopausal hormone therapy
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and health care professionals.
www.healio.com
katiekalvaitis.bsky.social
📰 #ENDO2025 may be over but Healio's coverage continues

Visit the link ⬇️ for the latest updates on:

📌 obesity drug benefits
📌 a new treatment for acromegaly
📌 once-monthly growth hormone therapy
📌 + more

@gohealio.bsky.social @reginaschaffer.bsky.social #Endosky

www.healio.com/news/endocri...
katiekalvaitis.bsky.social
🔥Highlights from day 2 #ACC25

📌 ALPACA
📌 BHF PROTECT-TAVI
📌 FRESH-UP
📌 Evolut Low Risk at 5 years
📌 DapaTAVI
📌 ADVANCE
📌 & more

All Healio Cardiology Today coverage in the link below

www.healio.com/news/cardiol...

#CardioSky
American College of Cardiology
The latest news from the ACC Annual Scientific Session, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention, heart failure and more.
www.healio.com
katiekalvaitis.bsky.social
New data on lepodisiran presented at #ACC25:

📌 substantial reductions in lipoprotein(a) at 6 months and 1 year vs placebo in phase 2 ALPACA study

📌 drug will allow infrequent administration

📌 a cardiovascular outcomes trial is underway

More below

www.healio.com/news/cardiol...
Lepodisiran lowers Lp(a) substantially with infrequent administration
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more than 90 percentage points with a single 400-mg dose compared with placeb...
www.healio.com
katiekalvaitis.bsky.social
DapaTAVI at #ACC25:

📌 The SGLT2 inhibitor #dapagliflozin was safe and effective in older adults undergoing TAVR who were at high risk for #heartfailure

📌 Genital infections, hypotension more common

📌 A “practice-changing trial”

Article below

www.healio.com/news/cardiol...
Dapagliflozin benefits older patients with heart failure undergoing valve replacement
CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with dapagliflozin compared with standard care alone, i...
www.healio.com
katiekalvaitis.bsky.social
More from day 1 #ACC25

📌 WARRIOR = the largest study of women with suspected ischemia with nonobstructive coronary disease

📌 Intensive medical therapy did not prevent 🫀 events for women with INOCA

📌 “This trial should not be considered a negative trial”

www.healio.com/news/cardiol...
Intensive medical therapy does not help or harm women with chest pain: WARRIOR
CHICAGO — Among women with suspected ischemia with nonobstructive coronary disease, an intensive medical therapy strategy did not reduce risk for major adverse CV events at 5 years compared with...
www.healio.com
katiekalvaitis.bsky.social
🔥Hot off the press:

Highlights from day 1 at #ACC25 #CardioSky

📌 WARRIOR
📌 STRIDE
📌 API-CAT
📌 SOUL
📌 RIVAWAR
📌 & more in the link

www.healio.com/news/cardiol...
https://healio.com/news/cardiolog…